May 20, 2021
Moores Cancer Center at UC San Diego Health joins other National Cancer Institute cancer centers in urging that HPV vaccinations get back on track as part of cancer prevention. Don’t delay. Save lives.
April 7, 2016
…“Mesa Consortium,” a new scientific hub for the Human Vaccines Project. Under a collaborative agreement, the Mesa Consortium and the Human Vaccine Project aim to transform current understanding of the human immune system and expedite development of vaccines and biologics to prevent and treat many global diseases.
August 4, 2022
…Advocates for the HPV Vaccine After Advanced Throat Cancer It was a typical morning for Mike West, one that usually started with a quick shave before getting ready for work. However, this specific morning, he felt something unusual: a small, but hard lump just under his skin on his throat.…
October 18, 2023
UC San Diego engineers have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs. Its success lies in targeting a protein known to play a central role in cancer growth and spread, rather than targeting the primary tumor itself.
January 27, 2016
In response to low national vaccination rates for the human papillomavirus (HPV), Moores Cancer Center at UC San Diego Health has joined 68 National Cancer Institute (NCI)-designated cancer centers in issuing a statement urging for increased HPV vaccination.
September 16, 2016
…this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program, headed by Vice President Joe…
October 17, 2017
…the doctors at Moores Cancer Center at UC San Diego Health. When their daughter’s cancer reappeared, it was the first place they turned for help. Because of their experience and trust in the medical and research staff, the couple recently donated $1 million to the University of California San Diego…
April 6, 2022
UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
July 1, 2016
The Human Vaccines Project is teaming with the Qualcomm Institute at the University of California San Diego to apply advances in machine learning to solve critical problems impeding the development of vaccines and therapeutics for a wide range of diseases.
August 5, 2021
Local public health leaders, including Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego, are calling on parents to protect children from preventable diseases, in particular the human papillomavirus (HPV) which is responsible for 36,000 new cancer diagnosis yearly.
